Abstract
Cystatins interfere in the functioning of antidepressant (MAOI) therefore MAOI may not be able to act on monoamine Oxidase (MAO) and the destruction of Serotonin continues which leads to depression. The effect of neurotransmitter has been studied to explore the serotonin induced cystatin dysfunction.
When 1μM of cystatin was treated with increasing concentrations of serotonin, the cystatin showed increase in fluorescence intensity and decrease in absorbance, functional study shows a continues loss in antiproteolytic activity with increasing concentration of serotonin results indicated unfolding of cystatin which may not be able to regulate the activity of cathepsins leading to protease- antiprotease imbalance, which may be a cause of several diseases.
Neurotransmitters are endogenous chemicals which relay, amplify, and modulate signals between a neuron and another cell. Release of neurotransmitters usually follows arrival of an action potential at the synapse, Serotonin is a monoamine neurotransmitter. It is synthesized in serotonergic neurons in the central nervous system (CNS) where it has various functions, including control of appetite, mood and anger. Cystatins are the inhibitors of cysteine proteinases most of which form equimolar complexes with their target enzymes.
They are the members of cystatin super family. They are present in a variety of tissues, body fluids of human beings and animals to regulate the activities of cysteine proteinases.
Keywords: Serotonin, Cystatin Antidepressant Neurotransmitter, Buffalo Brain Cystatin, Thiol Proteinase Inhibitors.
Current Nanoscience
Title:Interaction of Buffalo Brain Cystatin with Serotonin
Volume: 9 Issue: 2
Author(s): Fakhra Amin, Aabgeena Naim and Bilqees Bano
Affiliation:
Keywords: Serotonin, Cystatin Antidepressant Neurotransmitter, Buffalo Brain Cystatin, Thiol Proteinase Inhibitors.
Abstract: Cystatins interfere in the functioning of antidepressant (MAOI) therefore MAOI may not be able to act on monoamine Oxidase (MAO) and the destruction of Serotonin continues which leads to depression. The effect of neurotransmitter has been studied to explore the serotonin induced cystatin dysfunction.
When 1μM of cystatin was treated with increasing concentrations of serotonin, the cystatin showed increase in fluorescence intensity and decrease in absorbance, functional study shows a continues loss in antiproteolytic activity with increasing concentration of serotonin results indicated unfolding of cystatin which may not be able to regulate the activity of cathepsins leading to protease- antiprotease imbalance, which may be a cause of several diseases.
Neurotransmitters are endogenous chemicals which relay, amplify, and modulate signals between a neuron and another cell. Release of neurotransmitters usually follows arrival of an action potential at the synapse, Serotonin is a monoamine neurotransmitter. It is synthesized in serotonergic neurons in the central nervous system (CNS) where it has various functions, including control of appetite, mood and anger. Cystatins are the inhibitors of cysteine proteinases most of which form equimolar complexes with their target enzymes.
They are the members of cystatin super family. They are present in a variety of tissues, body fluids of human beings and animals to regulate the activities of cysteine proteinases.
Export Options
About this article
Cite this article as:
Amin Fakhra, Naim Aabgeena and Bano Bilqees, Interaction of Buffalo Brain Cystatin with Serotonin, Current Nanoscience 2013; 9 (2) . https://dx.doi.org/10.2174/1573413711309020011
DOI https://dx.doi.org/10.2174/1573413711309020011 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Next Steps in Alzheimers Disease Research: Interaction between Epidemiology and Basic Science
Current Alzheimer Research A Direct Correlation between Red Blood Cell Indices and Cognitive Impairment After Aneurysmal Subarachnoid Hemorrhage (aSAH)
Current Neurovascular Research Platelet Resistance to Antiplatelet Drugs
Recent Patents on Cardiovascular Drug Discovery Smoking and Hypertension: Independent or Additive Effects to Determining Vascular Damage?
Current Vascular Pharmacology An Insight into the Therapeutic Potential of Major Coffee Components
Current Drug Metabolism Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology
Current Drug Metabolism A Diabetes Treatment Strategy to Reduce the Risk of Cardiovascular Events: Clinical Benefits and Potential of Linagliptin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Properties and Clinical Development of a Novel Coating Technology: The poly[bis(trifluoroethoxy)phosphazene]
Recent Patents on Drug Delivery & Formulation Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry Ion Transporters in Brain Tumors
Current Medicinal Chemistry Atrial Fibrillation in Patients Undergoing Surgical Revascularization: An Update on Pharmacologic Prophylaxis
Cardiovascular & Hematological Agents in Medicinal Chemistry Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease
Current Medicinal Chemistry New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Current Drug Targets Na+-H+ Exchanger, pH Regulation and Cancer
Recent Patents on Anti-Cancer Drug Discovery Cardiovascular Risk, Inflammation and Physical Activity in Rheumatoid Arthritis
Current Rheumatology Reviews Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Current Drug Targets Impact of Hyperhomocyst(e)inemia on Endothelial Function
Vascular Disease Prevention (Discontinued) A Nanotechnological Approach to the Management of Alzheimer Disease and Type 2 Diabetes
CNS & Neurological Disorders - Drug Targets Editorial : Novel Therapeutic Targets for Cardiovascular Disease
Current Pharmaceutical Design Prevalence and Predictors of Overweight and Obesity in Patients with Pituitary Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets